Results for tag: "Trogarzo"

Trogarzo is a brand name for the HIV/AIDS drug ibalizumab-uiyk, which is used to treat HIV-1 infection in adults. It is a monoclonal antibody that works by blocking the entry of HIV-1 into human cells. Trogarzo is administered as an intravenous infusion every two weeks and is used in combination with other antiretroviral medications. Trogarzo is the first and only HIV-1 entry inhibitor approved by the U.S. Food and Drug Administration (FDA). The Trogarzo market is composed of a variety of companies that produce and distribute the drug. These companies include TaiMed Biologics, Inc., Theratechnologies, Inc., and ViiV Healthcare. Additionally, there are several generic drug manufacturers that produce generic versions of Trogarzo. These companies include Mylan N.V., Teva Pharmaceuticals, and Sandoz International GmbH. Show Less Read more